Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCorpus Resources PLC Regulatory News (COR)

  • This share is currently suspended. It was suspended at a price of 0.0155

Share Price Information for Corpus Resources PLC (COR)

Share Price is delayed by 15 minutes
Get Live Data
0.0155    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £982.13k
COR Live PriceLast checked at - London Stock Exchange

Intraday Corpus Resources PLC Share Chart

Re Contract

16 Mar 2005 07:02

Chorion PLC16 March 2005 ITV doubles its order for new Agatha Christie television films from Chorion Doubling of 2005 commission follows success of new Marple series London. Wednesday, 16 March 2005 -- Chorion PLC, the leading owner ofentertainment brands and content, today announced that ITV has commissioned anadditional tranche of television films based on the stories of the world's bestselling mystery writer Agatha Christie. Under the terms of Chorion's current output deal with ITV, the broadcaster iscontracted to purchase four films a year each year from 2003 to 2006. FourPoirot films were made in 2003, and in December 2004 four new Marple films,starring Geraldine McEwan, were broadcast. Following the ratings success ofthese productions, ITV has decided to increase its order for 2005. Chorion will now make eight Agatha Christie films in 2005, with a minimum of sixof them to be delivered this year and two early in 2006. Later in 2006, aminimum of a further four films will be delivered. The precise split betweenMarple and Poirot films has yet to be decided by the broadcaster. This increased commission for 2005 follows on from the success of the 2004 MissMarple films. In 2004, "Agatha Christie: Marple" was co-produced by Chorion,Granada and PBS. The four two-hour dramas averaged a 33% audience share; threeof the four films were the most-watched programmes in their fiercely-competitiveSunday evening timeslot. The series followed the template set by Poirot, witheach film featuring A-list casts, strong writers and high production values.Granada International is the distribution agent for these titles and it reportsthat international sales have so far have exceeded their expectations. Nicholas James, Chief Executive of Chorion plc said: "This is a valuable boost for Chorion. The continued demand for Agatha Christiefilms from ITV and broadcasters worldwide clearly demonstrates the company'sability to reinvent and reinvigorate a classic brand, and make it relevant formodern audiences. We look forward to broadening the appeal of the world'sgreatest mystery writer and bringing more of her classic stories to televisionscreens around the world." - ends - For enquiries or imagery please call:Tim Allan or Andrew ShollPortland, for Chorion020 7404 5344andrew.sholl@portlandpr.co.uk High resolution images are available for the media to view and download free ofcharge from www.vismedia.co.uk About Chorion Chorion (LSE: COR) is a leading owner and manager of classic literary-basedbrands. Its foremost properties include Enid Blyton's Noddy, Roger Hargreaves'Mr. Men and Little Miss series, Agatha Christie's Hercule Poirot and MissMarple, Georges Simenon's Inspector Maigret and Raymond Chandler's PhilipMarlowe. Visit www.chorion.co.uk. About Agatha Christie Universally known as the Queen of Crime, Agatha Christie wrote 80 novels andshort story collections as well as 19 plays. Her books have been translatedinto more than 100 languages and are estimated to have sold two billion copiesworldwide, making her the most widely published author in history, outsold onlyby the Bible and Shakespeare. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st May 20268:10 amRNSTemporary Suspension of Listing
27th Apr 20264:46 pmRNSHolding(s) in Company
24th Apr 20262:49 pmRNSHolding(s) in Company
23rd Apr 20261:20 pmRNSBoard Appointment, Fundraising & PDMR Dealings
23rd Apr 20269:57 amRNSHolding(s) in Company
21st Apr 202611:06 amRNSDelay in Audited Accounts & Temporary Suspension
14th Apr 20265:24 pmRNSHolding(s) in Company
25th Mar 20263:11 pmRNSHolding(s) in Company
20th Mar 20262:14 pmRNSHolding(s) in Company
18th Mar 20261:59 pmRNSHolding(s) in Company
25th Feb 20263:45 pmRNSHolding(s) in Company
26th Jan 20267:00 amRNSHolding(s) in Company
20th Jan 20264:15 pmRNSHolding(s) in Company
15th Jan 20264:22 pmRNSHolding(s) in Company
12th Jan 20262:23 pmRNSHolding(s) in Company
8th Jan 20264:10 pmRNSHolding(s) in Company
26th Sep 20252:28 pmRNSChange of Registered Office
26th Sep 20252:16 pmRNSHolding(s) in Company
23rd Sep 20251:00 pmRNSHolding(s) in Company
22nd Sep 20257:00 amRNSHalf-Year Results to 30 June 2025
28th Aug 202511:20 amRNSHolding(s) in Company
25th Jul 202512:05 pmRNSHolding(s) in Company
1st Jul 20255:32 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSDirector/PDMR Shareholding
27th Jun 202511:42 amRNSResult of AGM
23rd Jun 20258:51 amRNSPlacing
30th Apr 20254:50 pmRNSAnnual Financial Report
18th Feb 20254:19 pmRNSCorrection: Placing and PDMR
14th Feb 20253:31 pmRNSAdmission of Placing Shares & PDMR
11th Feb 20252:41 pmRNSPlacing
10th Dec 20242:21 pmRNSBoard Changes
19th Nov 20245:00 pmRNSNotice of Intended Dividend Payments
17th May 20064:24 pmRNSSecond Court Hearing
16th May 20067:00 amRNSSuspension - Chorion plc
15th May 20065:11 pmRNSFirst Court Hearing
12th May 20065:12 pmRNSStatement re Timetable
11th May 200612:52 pmRNSHolding(s) in Company
9th May 200611:51 amRNSRule 8.3- Chorion PLC
8th May 200610:57 amRNSRule 8.3- Chorion PLC
27th Apr 20066:16 pmRNSResult of EGM
26th Apr 20063:42 pmRNSRule 8.3- Chorion PLC
20th Apr 200611:09 amRNSRule 8.3- Chorion Plc
18th Apr 20066:21 pmRNSPosting of Revised Scheme Doc
13th Apr 200611:27 amRNSRule 8.3- Chorion Plc
12th Apr 20066:40 pmRNSStatement re Possible Offer
7th Apr 200612:20 pmRNSEPT Disclosure
6th Apr 20065:58 pmRNSRule 8.1- (Chorion Plc)
6th Apr 20064:41 pmRNSRule 8.3- (Chorion plc)
6th Apr 20064:30 pmRNSRule 8.3- (Chorion plc)
6th Apr 20061:31 pmRNSRule 8.1- (Chorion plc)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.